The article Beckley Psytech Launches Phase 2a study of 5-MeO-DMT for Alcohol Use Disorder was originally published on Microdose. Beckley Psytech is moving...
The munKNEE "Rags-to-Riches" Portfolio consists of 16 cannabis, psychedelic, and plant-based food stocks with market capitalizations between $400M and...
The article Small Pharma Announces Positive 6-month Data from Phase 2a DMT Trial was originally published on Microdose. Small Pharma releases additional...
On a warm spring day, March 28, 2023, I found myself once again making the trek to the city of Angels. As part of the Reality...
The company made $364,500 in licensing revenues. The post Psychedelic Research Firm Filament Health Grows Pipeline in 2022 appeared first on Green Market...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, released its fourth quarter...
The article Chrisitian Angermayer Shows Faith in Atai, Buys Another 1.2 M Shares was originally published on Microdose. On March 29th, Christian Angermayer,...
The article News You Might Have Missed: April 3rd, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The munKNEE Psychedelic Drug Stocks Index was DOWN 3.4% in March but is still UP 1.2% YTD and the average price targets of the above stocks represent...
The commission will be investigating the risks and benefits associated with MDMA-assisted therapy The post Dutch government establishes MDMA research...